[Multicentre study of percutaneous closure of interventricular muscular defects with the aid of an Amplatzer duct occluder prosthesis]
- PMID: 15214552
[Multicentre study of percutaneous closure of interventricular muscular defects with the aid of an Amplatzer duct occluder prosthesis]
Abstract
Percutaneous closure of interventricular defects is an alternative or adjunct to surgery with the disadvantage of a sometimes prolonged and difficult catheterisation only during which the choice of prosthesis can be determined. Despite the existence of an occlusion prosthesis, the Amplatzer Septal Defect Occluder, specifically conceived for this purpose, an arterial canal occlusion prosthesis such as the Amplatzer Duct Occluder is sometimes better suited for the occlusion of certain interventricular defects. Since 1999, 11 Amplatzer Duct Occluders were used for the closure of interventricular muscular defects, during 10 catheterisations in 9 patients with a median age of 2.5 (0.1 to 43.9) years. In 5 cases there were residual septal defects after failure of initial surgery. 10 were successful with prostheses of 6/4 mm to 12/10 mm while in one patient the interventricular communication had to be closed surgically because the 14/12 mm prosthesis could not be positioned due to a tortuous introduction route. The only complication was a pericardial effusion requiring surgical drainage in one infant. After a median follow up of 2.1 (0.3 to 4.2) years, all of the patients had a satisfactory functional status, with minimal residual shunt on echocardiography in 2 cases. The Amplatzer Duct Occluder therefore seems better adapted for the closure of post-operative residual interventricular communications, with a thickened interventricular septum or even when the tricuspid valve is very close to the right ventricular side of the orifice.
Similar articles
-
Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience.Kardiol Pol. 2008 Sep;66(9):941-7; discussion 948-9. Kardiol Pol. 2008. PMID: 18924021
-
Percutaneous closure of post-traumatic and congenital muscular ventricular septal defects with the Amplatzer Muscular VSD Occluder.Kardiol Pol. 2008 Jul;66(7):715-20; discussion 721. Kardiol Pol. 2008. PMID: 18690562
-
Transcatheter closure of muscular ventricular septal defect using the Amplatzer devices.Heart Lung Circ. 2006 Feb;15(1):12-7. doi: 10.1016/j.hlc.2005.02.005. Epub 2005 May 31. Heart Lung Circ. 2006. PMID: 16473785
-
Evolution of strategies for management of the patent arterial duct.Cardiol Young. 2007 Sep;17 Suppl 2:68-74. doi: 10.1017/S1047951107001175. Cardiol Young. 2007. PMID: 18039400 Review.
-
Technology Insight: transcatheter closure of ventricular septal defects.Nat Clin Pract Cardiovasc Med. 2005 Nov;2(11):592-6. doi: 10.1038/ncpcardio0351. Nat Clin Pract Cardiovasc Med. 2005. PMID: 16258571 Review.
Cited by
-
Percutaneous closure of traumatic ventricular septal defects: device selection and reasoning.Clinics (Sao Paulo). 2014 Feb;69(2):150-1. doi: 10.6061/clinics/2014(02)12. Clinics (Sao Paulo). 2014. PMID: 24519207 Free PMC article. No abstract available.
-
Percutaneous closure of a post-traumatic ventricular septal defect with a patent ductus arteriosus occluder.Clinics (Sao Paulo). 2012 Nov;67(11):1281-3. doi: 10.6061/clinics/2012(11)10. Clinics (Sao Paulo). 2012. PMID: 23184204 Free PMC article.
-
Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects.F1000Res. 2018 Apr 26;7:F1000 Faculty Rev-498. doi: 10.12688/f1000research.14102.1. eCollection 2018. F1000Res. 2018. PMID: 29770201 Free PMC article. Review.